{"id":3294,"date":"2023-08-07T13:41:50","date_gmt":"2023-08-07T11:41:50","guid":{"rendered":"https:\/\/www.ptc.cz\/co-liecime\/lymfomy\/protonova-lecba-lymfomu\/"},"modified":"2024-07-26T14:20:05","modified_gmt":"2024-07-26T12:20:05","slug":"protonova-liecba-malignych-lymfomov","status":"publish","type":"page","link":"https:\/\/www.ptc.cz\/sk\/co-liecime\/lymfomy\/protonova-liecba-malignych-lymfomov\/","title":{"rendered":"Prot\u00f3nov\u00e1 lie\u010dba mal\u00edgnych lymf\u00f3mov"},"content":{"rendered":"<div class=\"gdc_row\">\n<div class=\"gdc_column gdc_chalf\">\n<div class=\"gdc_inner\">\n<p>Na\u0161e postupy prot\u00f3novej r\u00e1dioterapie pri lie\u010dbe mal\u00edgneho lymf\u00f3mu v&nbsp;oblasti mediast\u00ednu (medzihrudia) boli zaraden\u00e9 do svetov\u00fdch lie\u010debn\u00fdch protokolov, s\u00fa preberan\u00e9 ostatn\u00fdmi svetov\u00fdmi prot\u00f3nov\u00fdmi centrami a&nbsp;umo\u017e\u0148uj\u00fa \u00faplne z\u00e1sadn\u00fdm sp\u00f4sobom zn\u00ed\u017ei\u0165 o\u017eiarenie napr. srdca a&nbsp;p\u013e\u00fac, a&nbsp;t\u00fdm v\u00fdznamne eliminova\u0165 riziko vzniku srdcov\u00fdch a&nbsp;p\u013e\u00facnych ochoren\u00ed (ako s\u00fa napr. srdcov\u00fd infarkt, poruchy srdcov\u00e9ho rytmu, p\u013e\u00facna fibr\u00f3za a&nbsp;i.).<\/p>\n<p><strong>Prot\u00f3nov\u00e1 lie\u010dba tie\u017e dok\u00e1\u017ee v\u00fdrazne eliminova\u0165 o\u017eiarenie miechy, a&nbsp;v\u010faka tomu zn\u00ed\u017ei\u0165 riziko jej po\u0161kodenia. Mal\u00edgne lymf\u00f3my s\u00fa ochorenie, ktor\u00e9 ve\u013emi \u010dasto postihuje osoby v&nbsp;mladom veku. Pacienti sa po onkologickej lie\u010dbe vo vysokom percente uzdravia, preto je \u017eiaduce v&nbsp;maxim\u00e1lnej mo\u017enej miere predch\u00e1dza\u0165 ak\u00fdmko\u013evek ved\u013eaj\u0161\u00edm \u00fa\u010dinkom lie\u010dby. Patr\u00ed k&nbsp;n\u00e1dorom vysoko citliv\u00fdm na&nbsp;lie\u010dbu \u017eiaren\u00edm. Lie\u010dba \u017eiaren\u00edm je v\u00e4\u010d\u0161inou odpor\u00fa\u010dan\u00e1 ako lie\u010dba doplnkov\u00e1 po predch\u00e1dzaj\u00facej syst\u00e9movej lie\u010dbe (chemoterapii, biologickej lie\u010dbe).<\/strong><\/p>\n<\/div>\n<\/div>\n<div class=\"gdc_column gdc_chalf\">\n<div class=\"gdc_inner\">\n<p>Problematika o\u017earovania mal\u00edgnych lymf\u00f3mov spo\u010d\u00edva v&nbsp;redukcii d\u00e1vky na&nbsp;okolit\u00e9 rizikov\u00e9 org\u00e1ny, ktor\u00e9 nie je vo v\u00e4\u010d\u0161ine pr\u00edpadov pri be\u017enej r\u00e1dioterapii spo\u013eahlivo dosiahnu\u0165. Z&nbsp;dlhodob\u00e9ho h\u013eadiska pacientov po lie\u010dbe \u017eiaren\u00edm ohrozuje najm\u00e4 v\u00fdvoj sekund\u00e1rnych malign\u00edt a&nbsp;kardiovaskul\u00e1rnych ochoren\u00ed. Z\u00e1sadn\u00e9 je v\u017edy starostliv\u00e9 zv\u00e1\u017eenie indik\u00e1cie o\u017eiarenia. Nutnos\u0165 zaradenia r\u00e1dioterapie do lie\u010debnej sch\u00e9my je potvrdzovan\u00e1 klinick\u00fdmi \u0161t\u00fadiami. V&nbsp;SR vych\u00e1dzame z&nbsp;odpor\u00fa\u010dan\u00ed Kooperat\u00edvnej lymf\u00f3movej skupiny (KLS), ktor\u00e9 reflektuj\u00fa najnov\u0161ie v\u00fdsledky t\u00fdchto klinick\u00fdch \u0161t\u00fadi\u00ed a&nbsp;s\u00fa pravidelne aktualizovan\u00e9. Pri vlastnom preveden\u00ed r\u00e1dioterapie vych\u00e1dzame aj z&nbsp;odpor\u00fa\u010dan\u00ed ILROG (International Lymphoma Radiation Oncology Group).<\/p>\n<p>Bolo potvrden\u00e9 14 \u0161t\u00fadiami, \u017ee prot\u00f3nov\u00e1 r\u00e1dioterapia v\u00fdrazne zni\u017euje radia\u010dn\u00fa z\u00e1\u0165a\u017e rizikov\u00fdch org\u00e1nov a&nbsp;mala by by\u0165 preto zva\u017eovan\u00e1 u&nbsp;pacientov, u&nbsp;ktor\u00fdch je schopn\u00e1 v\u00fdznamne zn\u00ed\u017ei\u0165 d\u00e1vky na&nbsp;rizikov\u00e9 \u0161trukt\u00fary.<\/p>\n<p><iframe loading=\"lazy\" title=\"Protonov\u00e1 l\u00e9\u010dba malign\u00edch lymfom\u016f\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/_camxJG2RZA?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":2894,"parent":3293,"menu_order":365,"comment_status":"closed","ping_status":"closed","template":"template-service-detail-with-anchor-sidebar.php","meta":{"footnotes":""},"class_list":["post-3294","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/pages\/3294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/comments?post=3294"}],"version-history":[{"count":4,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/pages\/3294\/revisions"}],"predecessor-version":[{"id":7053,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/pages\/3294\/revisions\/7053"}],"up":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/pages\/3293"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/media\/2894"}],"wp:attachment":[{"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/media?parent=3294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}